T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Agree Realty
ADC
$9.34B
| $31.3M | ﹤0.01% |
415,549
+360,694
| +658% | +$25.5M |
|
877
Rollins
ROL
$17.4B
| $31.3M | ﹤0.01% |
618,017
+1,669
| +0.3% | +$82.4K |
|
878
Skyward Specialty Insurance
SKWD
$2.39B
| $31.2M | ﹤0.01% |
764,805
+687,305
| +887% | +$26.6M |
|
879
Liberty Broadband Class C
LBRDK
$5.29B
| $31.1M | ﹤0.01% |
401,892
+339,973
| +549% | +$21M |
|
|
MBX
880
MBX Biosciences
MBX
$3.23B
| $31M | ﹤0.01% |
+1,192,938
| New | +$27.3M |
|
881
Littelfuse
LFUS
$11.4B
| $30.9M | ﹤0.01% |
116,592
+13,946
| +14% | +$3.59M |
|
882
AnaptysBio
ANAB
$1.66B
| $30.9M | ﹤0.01% |
923,117
+622,893
| +207% | +$21.3M |
|
|
SPNS
883
DELISTED
Sapiens International
SPNS
| $30.7M | ﹤0.01% |
823,008
-41,734
| -5% | -$1.52M |
|
884
Asbury Automotive
ABG
$3.78B
| $30.5M | ﹤0.01% |
127,957
+18,650
| +17% | +$4.39M |
|
885
Reddit
RDDT
$30.4B
| $30.3M | ﹤0.01% |
460,151
+148,003
| +47% | +$9.15M |
|
|
SFBS
886
ServisFirst Bancshares
SFBS
$5B
| $30.3M | ﹤0.01% |
376,878
+57,118
| +18% | +$4.35M |
|
887
Crocs
CROX
$6.36B
| $30.2M | ﹤0.01% |
208,796
+2,716
| +1% | +$371K |
|
888
Cincinnati Financial
CINF
$26.5B
| $30.1M | ﹤0.01% |
221,036
+2,391
| +1% | +$309K |
|
889
Shift4
FOUR
$3.79B
| $30.1M | ﹤0.01% |
339,418
+48,014
| +16% | +$3.64M |
|
890
Addus HomeCare
ADUS
$2.2B
| $30M | ﹤0.01% |
225,549
-5,774
| -2% | -$729K |
|
891
Waters Corp
WAT
$40.6B
| $30M | ﹤0.01% |
83,225
+1,373
| +2% | +$447K |
|
892
Kirby Corp
KEX
$7.26B
| $29.9M | ﹤0.01% |
244,396
+212,437
| +665% | +$25.3M |
|
893
Campbell Soup
CPB
$6.94B
| $29.9M | ﹤0.01% |
610,729
+341,450
| +127% | +$16.6M |
|
894
Immunome
IMNM
$3B
| $29.8M | ﹤0.01% |
2,036,307
+15,188
| +0.8% | +$216K |
|
895
Sarepta Therapeutics
SRPT
$1.95B
| $29.5M | ﹤0.01% |
236,533
-103,497
| -30% | -$14.3M |
|
896
Northern Trust
NTRS
$34.8B
| $29.4M | ﹤0.01% |
326,625
-5,840
| -2% | -$511K |
|
897
Palomar
PLMR
$3.37B
| $29.3M | ﹤0.01% |
310,003
-8,730
| -3% | -$804K |
|
898
Constellium
CSTM
$3.95B
| $29.3M | ﹤0.01% |
1,799,690
+43,467
| +2% | +$737K |
|
899
DoubleVerify
DV
$2.04B
| $29.2M | ﹤0.01% |
1,735,344
+413,804
| +31% | +$7.89M |
|
900
Aptiv
APTV
$10.2B
| $29.2M | ﹤0.01% |
405,750
-384,872
| -49% | -$26.9M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.